Skip to content

A Comparative Study on the Treatment of Chronic Ankle Instability

The Clinical Control Study on the Treatment of Chronic Ankle Instability

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035504
Enrollment
Unknown
Registered
2020-08-13
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic ankle instability

Interventions

control group:ligment augmetation
Experimental group:ligment debridement

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. patients with anterior lateral malleolus pain accompanied by chronic ankle instability arthroscopy, some normal ankle ligament tissue was found its continuity and tension still exist (18-50 years old) patients. After the operation; 2. the patient, according to the physical examination and medical history, the health condition is stable, can participate in the subsequent trial project, and can follow up according to the follow-up; 3. did not participate in other clinical trials within 3 months prior to participating in this clinical trial; 4. patients voluntarily participate in this clinical trial and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. other associated ankle diseases include: talar cartilage injury, early arthritis, avulsion fracture and other patients; 2. patients have mechanical instability of the ankle joint, including habitual sprain, examination of the chest drawer test positive; 3. arthroscopic surgery after cleaning found no normal ligament tissue; 4. patients with abnormal lower limb force line before operation; 5. mental incapacity or inability to understand the requirements for participation in the study in patients or patients with mental illness; 6. subjects are immunosuppressive, suffering from autoimmune diseases or immunosuppressive disorders; 7. chronic alcoholism, drug abuse and other patients; 8. the patient lives far away, is not expected to complete the follow-up; 9. expected non-adherence patients; 10. The researchers didn't think it was appropriate for the patients to be included.

Design outcomes

Primary

MeasureTime frame
ankle range;VAS score;SF-36 score;AOFAS score;ankle MRI;lower extremity strength;

Countries

China

Contacts

Public ContactJian Zou

Shanghai Sixth People's Hospital

sephirothzou@163.com+86 13817276419

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026